Team
Senior scientists, hands on the molecule
NovaMab is led by a small, senior team with deep experience in conjugation chemistry, antibody engineering, contained GMP manufacturing and analytical development for complex modalities. The people who scope your programme are the people who run it.
Leadership
The team building NovaMab
Dr Eleanor Vance
Chief Executive Officer
Two decades in biologics CDMO leadership and complex-modality manufacturing.
Dr Raj Patel
Chief Scientific Officer
Conjugation chemistry and site-specific ADC development across two organisations.
Dr Ingrid Sørensen
Head of GMP Manufacturing
Contained, high-potency GMP manufacture and clinical supply of conjugates.
Dr Marcus Chen
Head of Analytical Development
DAR, free-drug and potency analytics for conjugates and engineered formats.
Scientific Advisory Board
Guided by leaders in the field
- Prof. Caroline WebbAntibody engineering and bispecific format design, University of Oxford.
- Prof. Andreas VogelPayload-linker chemistry and site-specific conjugation, ETH Zürich.
- Dr Lucia RomanomRNA and lipid-nanoparticle development for emerging modalities.
- Dr Michael AureliusRegulatory CMC and control strategy for complex biologics.
Join the team
We are building a small, senior team of conjugation chemists, antibody engineers and manufacturing scientists. See our open roles.